Straumann Holding AG (SAUHY)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Straumann Holding AG (SAUHY) trades at $13.46 with AI Score 48/100 (Grade C). Straumann Holding AG is a global leader in tooth replacement and orthodontic solutions. Market cap: $21.46B, Sector: Healthcare.
Price live · AI analysis from Mar 15, 2026SAUHY stock analysis for 2026: Analysts have set a consensus price target of $15.00 for Straumann Holding AG, suggesting 11.4% upside from the current price of $13.46. The AI MoonshotScore is 48/100, indicating a neutral outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
SAUHY: the 1 perspectives are evenly split.
How is this calculated? →Straumann Holding AG (SAUHY) Healthcare & Pipeline Overview
Straumann Holding AG, a Swiss-based company, is a global leader in the dental implant and orthodontic solutions market, offering a comprehensive portfolio of implant systems, CADCAM prosthetics, and clear aligners. With a strong international presence and a focus on innovation, Straumann serves a diverse range of clinical needs and patient segments.
What Is the Investment Thesis for SAUHY?
Straumann Holding AG presents a notable research candidate due to its leading position in the growing dental implant and orthodontic solutions market. The company's strong brand reputation, diverse product portfolio, and global reach provide a solid foundation for continued growth. With a P/E ratio of 47.5 and a profit margin of 13.7%, Straumann demonstrates financial stability and profitability. Key growth catalysts include the increasing demand for dental aesthetics, the aging global population, and the expansion of digital dentistry solutions. The company's commitment to innovation and strategic acquisitions further strengthens its competitive advantage. However, potential risks include regulatory changes, competition from established and emerging players, and economic downturns affecting discretionary healthcare spending.
Based on FMP financials and quantitative analysis
SAUHY Key Highlights
- Market Cap of $21.46B reflects Straumann's strong position in the dental solutions market.
- P/E ratio of 47.5 indicates investor confidence in Straumann's earnings potential.
- Gross Margin of 70.1% demonstrates efficient cost management and premium pricing power.
- ROE of 17.0% highlights Straumann's effective utilization of equity to generate profits.
- Debt-to-Equity ratio of 19.35 indicates a conservative capital structure and manageable debt levels.
Who Are SAUHY's Competitors?
SAUHY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DHR Danaher Corporation | $193.75 | -2.11% | $137.13B | 69 |
| XRAY DENTSPLY SIRONA Inc. | $12.34 | +5.89% | $2.47B | — |
| ZIMV ZimVie Inc. | $18.99 | +0.00% | $535.63M | 46 |
| NYXH Nyxoah S.A. | $1.75 | +1.74% | $69.31M | 69 |
| KMTS Kestra Medical Technologies, Ltd. | $27.70 | +2.67% | $1.62B | 67 |
| ZTEK Zentek Ltd. | $0.46 | +2.88% | $49.90M | 63 |
| OMIC Singular Genomics Systems, Inc. | $20.01 | +0.00% | $50.77M | 61 |
| FSPKF Fisher & Paykel Healthcare Corporation Limited | $22.52 | +0.00% | $13.23B | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SAUHY's Key Strengths?
- Global market leader in dental implants.
- Strong brand reputation and customer loyalty.
- Comprehensive product portfolio.
- Extensive distribution network.
What Are SAUHY's Weaknesses?
- High price point compared to some competitors.
- Dependence on developed markets.
- Exposure to currency fluctuations.
What Could Drive SAUHY Stock Higher?
- Increasing demand for dental implants and orthodontic solutions due to an aging global population.
- Expansion of digital dentistry and clear aligner therapy markets.
- Potential regulatory approvals for new products and technologies.
- Strategic acquisitions to expand product portfolio and geographic reach.
- Continued investment in research and development to drive innovation.
What Are the Key Risks for SAUHY?
- Rich valuation — a P/E of 47.5 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Intense competition from established and emerging players.
- Regulatory changes and compliance requirements.
- Economic downturns affecting discretionary healthcare spending.
- Technological disruptions in the dental industry.
- Currency fluctuations affecting international sales and profitability.
What Are the Growth Opportunities for SAUHY?
- Expansion in Emerging Markets: Straumann has a significant opportunity to expand its presence in emerging markets, particularly in Asia Pacific and Latin America. These regions are experiencing rapid economic growth and increasing demand for advanced dental solutions. By leveraging its existing distribution network and tailoring its product offerings to local market needs, Straumann can capture a larger share of these high-growth markets. This expansion could contribute significantly to revenue growth over the next 3-5 years.
- Digital Dentistry Solutions: The increasing adoption of digital dentistry presents a significant growth opportunity for Straumann. The company's portfolio of intra-oral scanners, milling machines, and 3D printers enables dental professionals to streamline their workflows and improve treatment outcomes. By investing in research and development and expanding its digital solutions offerings, Straumann can capitalize on this growing trend and strengthen its competitive advantage. The digital dentistry market is expected to grow at a CAGR of 10-15% over the next 5 years.
- Clear Aligner Therapy: Straumann's ClearCorrect business offers significant growth potential in the rapidly expanding clear aligner therapy market. Clear aligners are becoming increasingly popular among patients seeking a discreet and convenient alternative to traditional braces. By investing in marketing and expanding its ClearCorrect product line, Straumann can capture a larger share of this growing market. The clear aligner market is projected to reach $5 billion by 2028.
- Strategic Acquisitions: Straumann has a history of successful acquisitions that have expanded its product portfolio and geographic reach. The company can continue to pursue strategic acquisitions to further strengthen its competitive position and accelerate growth. Potential acquisition targets include companies with complementary technologies, products, or distribution networks. These acquisitions can provide access to new markets, technologies, and customer segments.
- Regenerative Solutions: Straumann's regenerative solutions for tooth preservation, implant-site management, and implant preservation represent a significant growth opportunity. As the focus on preventative dentistry increases, the demand for regenerative solutions is expected to grow. By investing in research and development and expanding its regenerative solutions portfolio, Straumann can capitalize on this growing trend and improve patient outcomes. The regenerative dentistry market is projected to grow at a CAGR of 8-10% over the next 5 years.
What Opportunities Does SAUHY Have?
- Expansion in emerging markets.
- Growth in digital dentistry and clear aligner therapy.
- Strategic acquisitions to expand product portfolio.
- Increasing demand for cosmetic dentistry.
What Threats Does SAUHY Face?
- Intense competition from established and emerging players.
- Regulatory changes and compliance requirements.
- Economic downturns affecting discretionary healthcare spending.
- Technological disruptions in the dental industry.
What Are SAUHY's Competitive Advantages?
- Strong brand reputation and established market leadership in the dental implant market.
- Comprehensive product portfolio covering a wide range of dental solutions.
- Extensive global distribution network with a strong presence in key markets.
- Commitment to innovation and research and development.
- High switching costs for dental professionals due to training and familiarity with Straumann products.
What Does SAUHY Do?
Founded in 1954 and headquartered in Basel, Switzerland, Straumann Holding AG has evolved into a global leader in tooth replacement and orthodontic solutions. The company operates through five segments: Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations. Straumann's comprehensive product portfolio includes dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions. These products are used in tooth correction, replacement, restoration, and prevention of tooth loss. Straumann offers a wide array of implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products. The company also provides prosthetics, including angled solutions, connections, components, and molar solutions. Straumann's digital solutions encompass intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers, along with consumables like blocks, discs, resins, titanium bases, and abutment blanks. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. Straumann serves clinicals needs, patient segments, and healthcare systems across the globe.
What Products and Services Does SAUHY Offer?
- Develops and manufactures dental implants for tooth replacement.
- Offers CADCAM prosthetics for customized dental restorations.
- Provides orthodontic solutions, including clear aligners, for teeth straightening.
- Manufactures biomaterials for bone and tissue regeneration.
- Offers digital equipment and solutions, such as intra-oral scanners and 3D printers.
- Provides instruments and surgical sets for dental procedures.
- Offers online education and training for dental professionals.
How Does SAUHY Make Money?
- Sells dental implants, prosthetics, and orthodontic solutions to dental professionals and institutions.
- Generates revenue through a network of distribution subsidiaries, partners, and third-party distributors.
- Offers digital equipment and solutions with recurring revenue streams from consumables and software licenses.
What Industry Does SAUHY Operate In?
Straumann Holding AG operates in the medical instruments and supplies industry, which is experiencing steady growth driven by an aging global population, increasing demand for cosmetic dentistry, and technological advancements in dental solutions. The market is competitive, with key players focusing on innovation, product differentiation, and geographic expansion. Straumann's strong brand reputation, comprehensive product portfolio, and global distribution network position it favorably within this landscape. The increasing adoption of digital dentistry and clear aligner therapies presents significant growth opportunities for companies like Straumann.
Who Are SAUHY's Key Customers?
- Dental professionals, including dentists, orthodontists, and oral surgeons.
- Dental clinics and hospitals.
- Dental laboratories.
FY2026 estForward Outlook
Wall Street analysts project Straumann Holding AG revenue of about $2.74B for fiscal 2026, with EPS near $0.32. The estimate reflects 9 contributing analysts.
F-Score 7/9Financial Health
Straumann Holding AG's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 9.67 places it in the safe zone, indicating low near-term bankruptcy risk.
ROE 17%Key Financial Metrics
Return on equity for Straumann Holding AG stands at 16.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 9.3%, showing how much profit it generates from its asset base. SAUHY trades at a trailing price-to-earnings ratio of 47.47, above the Healthcare sector average of ~23x. Its free cash flow yield is 1.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.21 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.1%, the inverse of the P/E and a quick read on earnings relative to price.
Straumann Holding AG (SAUHY) Valuation Context
Valued at $21.46B, SAUHY is classified as a large-cap stock. Relative to its peer group, SAUHY's quantitative score of 48/100 is below the peer average of 63/100.
Company Profile
Straumann Holding AG operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Basel, CH. The company is led by CEO Guillaume Daniellot. SAUHY has traded publicly since 2014.
SAUHY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Global market leader in dental implants.
- Strong brand reputation and customer loyalty.
- Comprehensive product portfolio.
- Extensive distribution network.
Bear Case
- High price point compared to some competitors.
- Dependence on developed markets.
- Exposure to currency fluctuations.
- Potential: Intense competition from established and emerging players.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
SAUHY Latest News
-
ALGN or SAUHY: Which Is the Better Value Stock Right Now?
zacks.com · Jun 25, 2026
SAUHY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SAUHY.
Price Targets
Consensus target: $15.00
SAUHY MoonshotScore
What does this score mean?
The MoonshotScore rates SAUHY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Straumann Holding AG ADR Information Unsponsored
Straumann Holding AG (SAUHY) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: SAUH
SAUHY OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Straumann Holding AG (SAUHY) may not meet the minimum financial or reporting standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited information available to investors, and the lack of stringent listing requirements can increase the risk of investing in these securities. Investors should exercise caution and conduct thorough due diligence before investing in OTC Other securities, as they may be subject to greater price volatility and lower liquidity compared to exchange-listed stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Lower liquidity and higher price volatility.
- Potential for fraud or manipulation.
- Lack of regulatory oversight compared to exchange-listed stocks.
- Information asymmetry between the company and investors.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's growth prospects and potential risks.
- Check for any legal or regulatory issues.
- Consult with a financial advisor before investing.
- Understand the risks associated with investing in OTC securities.
- Established operating history as Straumann Holding AG since 1954.
- Global presence and operations in multiple countries.
- Leading market position in the dental implant industry.
- Partnerships with reputable distributors and healthcare providers.
- Presence of well-known brands such as Straumann, Neodent, and ClearCorrect.
SAUHY Healthcare Stock FAQ
What does Straumann Holding AG do?
Straumann Holding AG is a global leader in the dental implant and orthodontic solutions market. The company develops, manufactures, and markets a comprehensive range of products, including dental implants, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions. Straumann's products are used by dental professionals to replace missing teeth, correct dental misalignments, and improve overall oral health. The company serves a diverse range of clinical needs, patient segments, and healthcare systems through a network of distribution subsidiaries, partners, and third-party distributors.
What are the main risks for SAUHY?
Straumann Holding AG faces several risks, including intense competition from established and emerging players in the dental implant and orthodontic solutions market. Regulatory changes and compliance requirements can also impact the company's operations and profitability. Economic downturns may affect discretionary healthcare spending, reducing demand for dental procedures. Technological disruptions in the dental industry could render existing products obsolete. Additionally, currency fluctuations can affect international sales and profitability, as Straumann operates in multiple countries.
What are the key growth opportunities for SAUHY in healthcare?
Straumann Holding AG has several key growth opportunities within the healthcare sector. These include expanding its presence in emerging markets, particularly in Asia Pacific and Latin America, where demand for advanced dental solutions is increasing. The company can also capitalize on the growing adoption of digital dentistry by expanding its portfolio of intra-oral scanners, milling machines, and 3D printers. Furthermore, Straumann can leverage its ClearCorrect business to capture a larger share of the rapidly expanding clear aligner therapy market. Strategic acquisitions of companies with complementary technologies or products can also drive growth.
How does Straumann Holding AG navigate regulatory approval processes?
As a global provider of medical devices, Straumann Holding AG must navigate complex regulatory approval processes in various countries. The company's products are subject to regulatory requirements in markets such as the United States, Europe, and Asia. Straumann's regulatory strategy involves maintaining compliance with applicable regulations, conducting clinical trials to demonstrate product safety and efficacy, and working closely with regulatory agencies to obtain necessary approvals. The company's experience and expertise in navigating these processes are critical to its ability to bring new products to market and maintain its competitive position.
What are the key factors to evaluate for SAUHY?
Straumann Holding AG (SAUHY) holds an AI score of 48/100 (low). P/E: 47.5x vs the S&P 500's ~20-25x. Analysts target $15.00 (+11%). Not financial advice.
How frequently does SAUHY data refresh on this page?
SAUHY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SAUHY's recent stock price performance?
Straumann Holding AG (SAUHY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Global market leader in dental implants. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SAUHY overvalued or undervalued right now?
Straumann Holding AG (SAUHY) trades at 47.5x earnings. Analysts target $15.00 (+11%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending may provide further insights.
- OTC market data may be less reliable than exchange-listed data.